It’s nice to finally see the insanely overvalued big pharma rip-off king Eli Lilly (LLY) finally begin to fracture, having lost about 10% of its price in the past month.
It has a long, long way to go still.
It’s nice to finally see the insanely overvalued big pharma rip-off king Eli Lilly (LLY) finally begin to fracture, having lost about 10% of its price in the past month.
It has a long, long way to go still.